Skip to main content

Advertisement

Log in

Toltrazuril treatment of congenitally acquired Neospora caninum infection in newborn mice

  • Original Paper
  • Published:
Parasitology Research Aims and scope Submit manuscript

Abstract

C57BL/6 mice were infected with Neospora caninum tachyzoites during pregnancy, yielding a transplacental infection of developing fetuses. Subsequently, congenitally infected newborn mice were treated either once or three times with toltrazuril (or placebo) at a concentration of 31.25 mg compound per kg body weight. Both toltrazuril and placebo treatment had no negative effect on newborns, as noninfected treated pups developed normally without differences in mortality and morbidity to matching nontreated control animals. Already one application of toltrazuril was significantly (p < 0.01) able to delay the outbreak of neosporosis in newborn mice, when compared to placebo-treated infected controls. We found significantly higher proportion of surviving newborns in one-time-toltrazuril-treated and three-time-toltrazuril-treated groups (34% and 54%, respectively) when compared to one-time-placebo-treated and three-time-placebo-treated groups (14% and 30%, respectively). There was no significant difference (p = 0.2) in the proportion of surviving pups between one-time-toltrazuril and three-time-toltrazuril treatment. However, the number of diseased and Neospora-positive pups (46% and 47%, respectively) was markedly reduced after three-time-toltrazuril treatment compared to all other groups. Three-time-treatment also resulted in the highest antibody (IgG, IgG2a) response. Pharmacokinetic analyses using individual serum samples revealed that, although toltrazuril was absorbed and metabolized to toltrazuril sulfone by newborn mice, medicated animals exhibited an unexpected rapid turn-over (half-life time) of the compound. Toltrazuril and the metabolite were also found in brain tissues, indicating that passage of the blood–brain barrier occurred. In conclusion, we could show that three times treatment with toltrazuril had a high impact on the course of infection in congenitally N. caninum-infected newborn mice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Adkins B, Du RQ (1998) Newborn mice develop balanced Th1/Th2 primary effector responses in vivo but are biased to Th2 secondary responses. J Immunol 160:4217–4224

    CAS  PubMed  Google Scholar 

  • Ammann P, Waldvogel A, Breyer I, Esposito M, Müller N, Gottstein B (2004) The role of B- and T-cell immunity in toltrazuril-treated C57BL/6 WT, µMT and nude mice experimentally infected with Neospora caninum. Parasitol Res 93:178–187

    Article  PubMed  Google Scholar 

  • Andrianarivo AG, Rowe JD, Barr BC, Anderson ML, Packham AE, Sverlow KW, Choromanski L, Loui C, Grace A, Conrad PA (2000) A POLYGEN-adjuvanted killed Neospora caninum tachyzoite preparation failed to prevent foetal infection in pregnant cattle following i.v./i.m. experimental tachyzoite challenge. Int J Parasitol 30:985–990

    Article  CAS  PubMed  Google Scholar 

  • Cannas A, Naguleswaran A, Müller N, Eperon S, Gottstein B, Hemphill A (2003a) Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines. Parasitology 126:303–312

    Article  CAS  PubMed  Google Scholar 

  • Cannas A, Naguleswaran A, Müller N, Gottstein B, Hemphill A (2003b) Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant. J Parasitol 89:44–50

    Article  CAS  PubMed  Google Scholar 

  • Darius AK, Mehlhorn H, Heydorn AO (2004a) Effects of toltrazuril and ponazuril on Hammondia heydorni (syn. Neospora caninum) infections in mice. Parasitol Res 92:520–522

    Article  PubMed  Google Scholar 

  • Darius AK, Mehlhorn H, Heydorn AO (2004b) Effects of toltrazuril and ponazuril on the fine structure and multiplication of tachyzoites of the NC-1 strain of Neospora caninum (a synonym of Hammondia heydorni) in cell cultures. Parasitol Res 92:453–458

    Article  PubMed  Google Scholar 

  • Debache K, Guionaud C, Alaeddine F, Mevissen M, Hemphill A (2008) Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites. Int J Parasitol 38:1455–1463

    Article  CAS  PubMed  Google Scholar 

  • Dubey JP (2003) Review of Neospora caninum and neosporosis in animals. Korean J Parasitol 41:1–16

    Article  CAS  PubMed  Google Scholar 

  • Dubey JP, Schares G, Ortega-Mora LM (2007) Epidemiology and control of neosporosis and Neospora caninum. Clin Microbiol Rev 20:323–367

    Article  CAS  PubMed  Google Scholar 

  • Eperon S, Brönnimann K, Hemphill A, Gottstein B (1999) Susceptibility of B-cell deficient C57BL/6 (µMT) mice to Neospora caninum infection. Parasite Immunol 21:225–236

    Article  CAS  PubMed  Google Scholar 

  • Esposito M, Stettler R, Moores SL, Pidathala C, Müller N, Stachulski A, Berry NG, Rossignol JF, Hemphill A (2005) In vitro efficacies of nitazoxanide and other thiazolides against Neospora caninum tachyzoites reveal antiparasitic activity independent of the nitro group. Antimicrob Agents Chemother 49:3715–323

    Article  CAS  PubMed  Google Scholar 

  • Esposito M, Müller N, Hemphill A (2007) Structure–activity relationships from in vitro efficacies of the thiazolide series against the intracellular apicomplexan protozoan Neospora caninum. Int J Parasitol 37:183–190

    Article  CAS  PubMed  Google Scholar 

  • Furr M, Kennedy T (2000) Cerebrospinal fluid and blood concentrations of toltrazuril 5% suspension in the horse after oral dosing. Vet Ther 1:123–132

    Google Scholar 

  • Gottstein B, Eperon S, Dai WJ, Cannas A, Hemphill A, Greif G (2001) Efficacy of toltrazuril and ponazuril against experimental Neospora caninum infection in mice. Parasitol Res 87:43–48

    Article  CAS  PubMed  Google Scholar 

  • Gottstein B, Razmi GR, Ammann P, Sager H, Müller N (2005) Toltrazuril treatment to control diaplacental Neospora caninum transmission in experimentally infected pregnant mice. Parasitology 130:41–48

    Article  CAS  PubMed  Google Scholar 

  • Greif G (2000) Immunity to coccidiosis after treatment with toltrazuril. Parasitol Res 86:787–790

    Article  CAS  PubMed  Google Scholar 

  • Haberkorn A (1996) Chemotherapy of human and animal coccidioses: state and perspectives. Parasitol Res 82:193–199

    Article  CAS  PubMed  Google Scholar 

  • Härdi C, Hässig M, Sager H, Greif G, Staubli D, Gottstein B (2006) Humoral immune reaction of newborn calves congenitally infected with Neospora caninum and experimentally treated with toltrazuril. Parasitol Res 99:534–540

    Article  Google Scholar 

  • Häsler B, Regula G, Stärk KDC, Sager H, Gottstein B, Reist M (2006a) Financial analysis of various strategies for the control of Neospora caninum in dairy cattle in Switzerland. Prev Vet Med 77:230–253

    Article  PubMed  Google Scholar 

  • Häsler B, Stärk KDC, Sager H, Gottstein B, Reist M (2006b) Simultaing the impact of four control strategies on the population dynamics of Neospora caninum infection in Swiss dairy cattle. Prev Vet Med 77:254–283

    Article  PubMed  Google Scholar 

  • Häsler B, Stärk K, Gottstein B, Reist M (2008) Epidemiologische und finanzielle Entscheidungsgrundlagen zur Kontrolle von Neospora caninum auf Schweizer Milchviehbetrieben. Schweiz Arch Tierh.kd 150:273–280

    Article  Google Scholar 

  • Hemphill A, Gottstein B (2000) A European perspective on Neospora caninum. Int J Parasitol 30:877–924

    Article  CAS  PubMed  Google Scholar 

  • Hemphill A, Gottstein B, Kaufmann H (1996) Adhesion and invasion of bovine endothelial cells by Neospora caninum. Parasitology 112:183–197

    Article  CAS  PubMed  Google Scholar 

  • Innes EA, Andrianarivo AG, Björkman C, Williams DJ, Conrad PA (2002) Immune responses to Neospora caninum and prospects for vaccination. Trends Parasitol 18:497–504

    Article  CAS  PubMed  Google Scholar 

  • Innes EA, Vermeulen AN (2006) Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora. Parasitology 133(Suppl):S145–168

    Article  PubMed  Google Scholar 

  • Kritzner S, Sager H, Blum J, Krebber R, Greif G, Gottstein B (2002) An explorative study to assess the efficacy of toltrazuril-sulfone (ponazuril) in calves experimentally infected with Neospora caninum. Ann Clin Microbiol Antimicrob 1:4

    Article  PubMed  Google Scholar 

  • Leepin A, Stüdli A, Brun R, Stephen CE, Boykin DW, Hemphill A (2008) Host cells participate in the in vitro effects of novel diamidine analogues against tachyzoites of the intracellular apicomplexan parasites Neospora caninum and Toxoplasma gondii. Antimicrob Agents Chemother 52:1999–2008

    Article  CAS  PubMed  Google Scholar 

  • Liddell S, Jenkins MC, Collica CM, Dubey JP (1999) Prevention of vertical transfer of Neospora caninum in BALB/c mice by vaccination. J Parasitol 85:1072–1075

    Article  CAS  PubMed  Google Scholar 

  • Lindsay DS, Dubey JP (1989) Evaluation of anti-coccidial drugs’ inhibition of Neospora caninum development in cell cultures. J Parasitol 75:990–992

    Article  CAS  PubMed  Google Scholar 

  • Lindsay DS, Dubey JP (1990) Effects of sulfadiazine and amprolium on Neospora caninum (Protozoa: Apicomplexa) infection in mice. J Parasitol 76:177–179

    Article  CAS  PubMed  Google Scholar 

  • Lindsay DS, Rippey NS, Cole RA, Parsons LC, Dubey JP, Tidwell RR, Blagburn BL (1994) Examination of the activities of 43 chemotherapeutic agents against Neospora caninum tachyzoites in cultured cells. Am J Vet Res 55:976–981

    CAS  PubMed  Google Scholar 

  • Morein B, Abusugra I, Blomqvist G (2002) Immunity in neonates. Vet Immunol Immunopathol 87:207–213

    Article  CAS  PubMed  Google Scholar 

  • Müller N, Zimmermann V, Hentrich B, Gottstein B (1996) Diagnosis of Neospora caninum and Toxoplasma gondii infection by PCR and DNA hybridization immunoassay. J Clin Microbiol 34:2850–2852

    PubMed  Google Scholar 

  • Nishikawa Y, Xuan X, Nagasawa H, Igarashi I, Fujisaki K, Otsuka H, Mikami T (2001) Prevention of vertical transmission of Neospora caninum in BALB/c mice by recombinant vaccinia virus carrying NcSRS2 gene. Vaccine 19:1710–1716

    Article  CAS  PubMed  Google Scholar 

  • Ortega-Mora LM, Gottstein B, Conraths FJ, Buxton D (eds) (2007) Protozoal abortion in farm ruminants; guidelines for diagnosis and control. CAB International, Wallingford

  • Strohbusch M, Müller N, Hemphill A, Greif G, Gottstein B (2008) NcGRA2 as a molecular target to assess the parasiticidal activity of toltrazuril against Neospora caninum. Parasitology 135:1065–1073

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The study was supported by Bayer HealthCare GmbH (Leverkusen), the Swiss Federal Office of Science and Education (BBW C01.0122 in the frame of COST 854), and the Swiss National Science Foundation (3100A0-112532/1).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. Gottstein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Strohbusch, M., Müller, N., Hemphill, A. et al. Toltrazuril treatment of congenitally acquired Neospora caninum infection in newborn mice. Parasitol Res 104, 1335–1343 (2009). https://doi.org/10.1007/s00436-009-1328-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00436-009-1328-x

Keywords

Navigation